Real-World Data at COTA

Patient health data is at the core of almost every healthcare technology innovation. Collected and stored across computers, mobile devices, wearables, and other technologies, this data, collectively, is called real-world data (RWD). This page serves as a library of how we see RWD driving value in the cancer space.

Why use Real-World Data?

At COTA, we curate regulatory-grade oncology RWD with the most relevance for our life sciences and provider partners, whether that involves supporting regulatory filings or research questions.  We cannot unlock the full value of RWD without the highest-quality collection and curation methodology, and we are powering a revolution in the development of new cancer therapies to bring clarity to cancer care.

 

How we define regulatory-grade data:

Provenance

  • COTA oversees the entire process from abstraction of raw data to final delivery of curated RWD
  • Traceability of all our data: where it originates, the transformations applied, and QA checks along the way

Relevance

  • The right cohorts after applying inclusion/exclusion criteria at the right volumes

  • Representativeness across real-world and clinical trial populations

  • Coverage across geographies of interest

Fidelity

  • Faithful representation of the original clinical data documented in EHR
  • Technology-enabled human abstraction leveraged to understand and capture clinical nuances
  • Accuracy of capture ensured through documented, multi-step QA/QC process
cotaIMG2

We have a responsibility to drive the use of RWD by consistently improving our data and demonstrating its utility. Our data has been used to support FDA and EMA submissions, explain care patterns, understand patient outcomes, and much more – and we anticipate the number of use cases to multiply in the coming years as RWD is explored and leveraged by more and more innovators in the industry.

Request a Demo

  • This field is for validation purposes and should be left unchanged.

How Are You Looking to Use RWD?

Browse related research, case studies and other resources that highlight examples of how RWD is being used today.

RWD Resources

COTA and Google Partner to Use Natural Language Processing to Harness Unstructured Data

We are excited to announce our partnership with Google Cloud to use their Natural Language Processing (NLP) technology to help us better understand the unstructured data in cancer patients’ medical records.

This is a key part of our mission to provide the most comprehensive cancer care possible by leveraging the latest advances in data science and technology.

Read More

COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation

New financing will help COTA expand RWD platform & services to drive more efficient and inclusive drug development.

Read More

Early Detection Saves Lives: A Real World Breast Cancer Story

When it comes to cancer, there are a lot of myths and misconceptions out there. But the one thing is for certain: cancer can affect anyone, at any time, and from any background. Hear from one of our own about their battle with breast cancer and how early detection helped them defeat cancer.

Read More

Interested in learning more about how we can transform cancer care together?

Join the Conversation

Find COTA at upcoming events, and see where we’ve been.
No event found!

Past Events

06Aug

JSM 2022

Walter E. Washington Convention Center
15May

ISPOR 2022

Gaylord National Resort & Convention Center
13May

AUA 2022

New Orleans Ernest N. Morial Convention Center
No event found!
Load More

Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry
  • This field is for validation purposes and should be left unchanged.